1. Opening Hook
Some companies blame rain gods; Alkyl Amines blames Washington. The US sanctions apparently hit everything from their distributors to their export dreams — proving once again that chemicals and geopolitics make for a volatile mix. Still, the management insists it’s “subdued, not sunk.” With Chinese rivals dumping and new players like Aarti joining the methylamine party, Alkyl’s calm tone almost feels like Zen under ammonia fumes. But hold on — they’re brewing a ₹120-crore new product in Kurkumbh and banking on anti-dumping duties to restore the shine. The story gets chemical — and political — as we dig in.
2. At a Glance
- Revenue Flat: Volumes up, prices down — the equation every CFO loves to hate.
- Margins Stable: Thanks to cost control and caffeine, not demand.
- PAT Steady: Because “flat” is the new “resilient.”
- Exports to US – 1% of sales: Uncle Sam still dictates the mood.
- Acetonitrile Prices: Slightly better post anti-dumping, but China just yawned and dropped prices again.
- Capex: ₹120 Cr at Kurkumbh — because optimism is tax-free.
3. Management’s Key Commentary
“Demand is subdued due to US sanctions and Chinese aggression.”
(Translation: Global trade is a group project, and everyone copied China’s answers. 😏)
“Methylamines face overcapacity; Aarti Drugs entered the scene.”
(When even your competitor’s competitor joins the party, it’s officially crowded.)
“Ethylamines stable; pharma customers still ordering.”
(Because domestic demand doesn’t need visas.)
“Acetonitrile anti-dumping duty helped, but Chinese prices ruined the party.”
(It’s like getting a gift, only to have your neighbor sell it cheaper.)
“New product of ₹120 Cr Capex—import substitute, unique in India.”
(Finally, something we make that China doesn’t. Yet.)
“GLP-1 diabetes drugs may lift acetonitrile demand.”
(Weight loss drugs might just make Alkyl’s topline heavier.)
“Agrochem demand is subdued but ‘touchwood’ recovering.”
(Yes, even chemists rely on wood now.)
